未登录

J

Jay S. Desgrosellier

University of California System

H指数:19

被引数:6,083

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

S100A8/A9 innate immune signaling as a distinct mechanism driving progression of smoking-related breast cancers

S100A8/A9固有免疫信号作为一种驱动吸烟相关乳腺癌进展的独特机制

IF7.3

2025-01-250

OA

Key antiviral response genes mediate the impact of chromosomal instability on breast cancer stemness

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Chronic use of tobacco products promotes breast cancer progression through α7 nAChR/STING pathway activation

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Breast cancer stem cells tolerate chromosomal instability during tumor progression via c-Jun/AXL stress signaling

CANCER RESEARCH

IF16.6

2024-02-010

PRE

Breast cancer stem cells tolerate chromosomal instability during tumor progression via c-Jun/AXL stress signaling

乳腺癌干细胞通过c-6月/AXL应激信号耐受肿瘤进展过程中的染色体不稳定性

IF3.6

2023-09-014

OAAI

Stem-like breast cancer cells in the activated state resist genetic stress via TGFBI-ZEB1

NPJ BREAST CANCER

IF7.6

2022-01-1312

OAAI

An integrin αvβ3+stem-like tumor cell subset promotes breast cancer progression via c-Jun/AXL signaling

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Combined Bcl-2/Src inhibition synergize to deplete stem-like breast cancer cells

IF10.1

2019-08-0118

OAAI

Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2017-12-1139

OA

Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers

CANCER DISCOVERY

IF33.3

2017-12-0483

OAAI

PUMA expression targets αvβ3/Slug+ stem-like tumor cells to prevent breast cancer progression independent of subtype

CANCER RESEARCH

IF16.6

2016-07-150

PRE

Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance

TRENDS IN CELL BIOLOGY

IF18.1

2015-04-01606

OAAI

Targeting Galectin-3 to reverse tumor stemness and drug resistance

CANCER RESEARCH

IF16.6

2014-10-011

PRE

Integrin αvβ3 drives Slug activation and stemness in the pregnant and neoplastic mammary gland

CANCER RESEARCH

IF16.6

2014-10-010

PRE

β3 integrin/KRAS/RalB complex drives tumor stemness and resistance to EGFR inhibition

CANCER RESEARCH

IF16.6

2014-10-010

PRE

Integrin αvβ3 Drives Slug Activation and Stemness in the Pregnant and Neoplastic Mammary Gland

DEVELOPMENTAL CELL

IF8.7

2014-08-0189

OAAI

Integrin αvβ3 drives the mammary stem cell state during pregnancy

MOLECULAR CANCER RESEARCH

IF4.7

2014-07-310

PRE

Integrin αVβ3 drives stemness in the pregnant and neoplastic mammary gland

CANCER RESEARCH

IF16.6

2014-05-010

PRE

An integrin β3-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition

NATURE CELL BIOLOGY

IF19.1

2014-04-20343

OA

PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2013-05-1379

OAAI